effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)-Reference-Cited by-同舟云学术

effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)

Published:2002-08 Issue:4 Volume:40 Page:662-668
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bonz Andreas W,Lengenfelder Björn,Strotmann Jörg,Held Stefanie,Turschner Oliver,Harre Kerstin,Wacker Christian,Waller Christiane,Kochsiek Nikolaus,Meesmann Malte,Neyses Ludwig,Schanzenbächer Peter,Ertl Georg,Voelker Wolfram

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation;Hall;Circulation,1996

2. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients;Urban;Circulation,1998

3. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;N Engl J Med,2001

4. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction;Wu;Circulation,1998

5. Clinical implications of the “no reflow” phenomenon;Ito;Circulation,1996

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study;European Heart Journal;2020-01-03

2. Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia;International Journal of Cardiology;2019-12

3. Identification of patients at higher risk for myocardial injury following elective coronary artery intervention;Catheterization and Cardiovascular Interventions;2019-10-22

4. Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management;Expert Review of Cardiovascular Therapy;2019-08-03

5. Safety and Efficacy of Periprocedural Heparin Plus a Short-Term Infusion of Tirofiban Versus Bivalirudin Monotherapy in Patients Who Underwent Percutaneous Coronary Intervention (from the Intermountain Heart Institute STAIR Observational Registry);The American Journal of Cardiology;2019-06